88 filings
8-K
GNLB
Genelabs Technologies Inc
9 Jan 09
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
GNLB
Genelabs Technologies Inc
13 Nov 08
Results of Operations and Financial Condition
12:00am
8-K
GNLB
Genelabs Technologies Inc
3 Nov 08
Entry into a Material Definitive Agreement
12:00am
8-K/A
GNLB
Genelabs Technologies Inc
30 Oct 08
Departure of Directors or Principal Officers
12:00am
8-K
GNLB
Genelabs Technologies Inc
7 Oct 08
Departure of Directors or Principal Officers
12:00am
8-K
azquwx
4 Sep 08
Departure of Directors or Principal Officers
12:00am
8-K
e1in ueqy892a
12 Aug 08
Results of Operations and Financial Condition
12:00am
8-K
051 d67o8441kit
10 Jul 08
Changes in Registrant.s Certifying Accountant
12:00am
8-K
0zw01qf72 4y
23 Jun 08
Genelabs Provides Update on Hepatitis C Drug Development With Collaboration Partners
12:00am
8-K
bxh o6y995ugja
14 May 08
Genelabs Reports Results for the First Quarter of 2008 and Progress on Operational Priorities
12:00am
8-K
y4why77j
25 Apr 08
Genelabs Technologies, Inc. Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQ’s Minimum Closing Bid Price Rule
12:00am
8-K
fw3dv
11 Feb 08
Departure of Directors or Principal Officers
12:00am
8-K
isbn5y njudp00mg6lc
31 Jan 08
Departure of Directors or Principal Officers
12:00am
8-K
rtotl72o0thw37p
21 Nov 07
Termination of a Material Definitive Agreement
12:00am
8-K
vz3p8p15wncpl75 9r
13 Nov 07
Genelabs Technologies, Inc. Reports
12:00am
8-K
opu ykmtbfc
30 Oct 07
Genelabs Technologies Announces Appointment of Frederick W. Driscoll As Chief Financial Officer
12:00am
8-K
24a820yda5ezv
1 Oct 07
Genelabs Technologies Announces Completion of
12:00am
8-K
s3le n75m
26 Sep 07
Other Events
12:00am
8-K
u669g5h92n ss
16 Aug 07
Departure of Directors or Principal Officers
12:00am
8-K
bv3ai
14 Aug 07
Results of Operations and Financial Condition
12:00am